Frazier Life Sciences Management as of Dec. 31, 2024
Portfolio Holdings for Frazier Life Sciences Management
Frazier Life Sciences Management holds 50 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 17.0 | $409M | 16M | 25.70 | |
| Mirum Pharmaceuticals (MIRM) | 11.3 | $272M | 6.6M | 41.35 | |
| Verona Pharma Sponsored Ads (VRNA) | 6.5 | $157M | 3.4M | 46.44 | |
| Krystal Biotech (KRYS) | 5.1 | $124M | 789k | 156.66 | |
| Arcutis Biotherapeutics (ARQT) | 5.1 | $122M | 8.8M | 13.93 | |
| Disc Medicine (IRON) | 4.6 | $111M | 1.8M | 63.40 | |
| Mbx Biosciences (MBX) | 4.6 | $110M | 6.0M | 18.43 | |
| Rhythm Pharmaceuticals (RYTM) | 4.3 | $105M | 1.9M | 55.98 | |
| Bridgebio Pharma (BBIO) | 4.3 | $104M | 3.8M | 27.44 | |
| Tarsus Pharmaceuticals (TARS) | 3.6 | $88M | 1.6M | 55.37 | |
| Phathom Pharmaceuticals (PHAT) | 3.4 | $82M | 10M | 8.12 | |
| Erasca (ERAS) | 2.0 | $49M | 19M | 2.51 | |
| Vaxcyte (PCVX) | 1.8 | $44M | 539k | 81.86 | |
| Trevi Therapeutics (TRVI) | 1.8 | $44M | 11M | 4.12 | |
| Revolution Medicines (RVMD) | 1.8 | $44M | 998k | 43.74 | |
| Kalvista Pharmaceuticals (KALV) | 1.7 | $41M | 4.9M | 8.47 | |
| Agios Pharmaceuticals (AGIO) | 1.5 | $35M | 1.1M | 32.86 | |
| Edgewise Therapeutics (EWTX) | 1.4 | $34M | 1.3M | 26.70 | |
| Soleno Therapeutics (SLNO) | 1.3 | $31M | 699k | 44.95 | |
| Oric Pharmaceuticals (ORIC) | 1.3 | $31M | 3.9M | 8.07 | |
| Ultragenyx Pharmaceutical (RARE) | 1.2 | $28M | 659k | 42.07 | |
| Savara (SVRA) | 1.1 | $27M | 8.7M | 3.07 | |
| Cg Oncology (CGON) | 0.9 | $22M | 770k | 28.68 | |
| Hillevax | 0.9 | $22M | 11M | 2.07 | |
| Anaptysbio Inc Common (ANAB) | 0.9 | $21M | 1.6M | 13.24 | |
| Rocket Pharmaceuticals (RCKT) | 0.8 | $19M | 1.5M | 12.57 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.8 | $18M | 133k | 137.67 | |
| Mereo Biopharma Group Spon Ads (MREO) | 0.7 | $18M | 5.1M | 3.50 | |
| Alkermes SHS (ALKS) | 0.7 | $17M | 601k | 28.76 | |
| Merus N V (MRUS) | 0.7 | $16M | 373k | 42.05 | |
| Immatics SHS (IMTX) | 0.6 | $15M | 2.1M | 7.11 | |
| Pliant Therapeutics (PLRX) | 0.6 | $15M | 1.1M | 13.17 | |
| Design Therapeutics (DSGN) | 0.5 | $12M | 2.0M | 6.17 | |
| Oruka Therapeutics (ORKA) | 0.5 | $11M | 583k | 19.39 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.5 | $11M | 4.6M | 2.35 | |
| Macrogenics (MGNX) | 0.4 | $10M | 3.2M | 3.25 | |
| Day One Biopharmaceuticals I (DAWN) | 0.4 | $8.7M | 690k | 12.67 | |
| ACADIA Pharmaceuticals (ACAD) | 0.4 | $8.6M | 470k | 18.35 | |
| Silence Therapeutics Ads (SLN) | 0.3 | $7.9M | 1.1M | 6.88 | |
| Palvella Therapeutics Inc Ne (PVLA) | 0.3 | $7.8M | 654k | 12.00 | |
| 89bio (ETNB) | 0.3 | $7.8M | 1.0M | 7.82 | |
| Cogent Biosciences (COGT) | 0.3 | $7.3M | 937k | 7.80 | |
| Newamsterdam Pharma Company *w Exp 99/99/999 (NAMSW) | 0.3 | $7.1M | 500k | 14.25 | |
| Lexeo Therapeutics (LXEO) | 0.3 | $6.3M | 956k | 6.58 | |
| Allogene Therapeutics (ALLO) | 0.3 | $6.1M | 2.9M | 2.13 | |
| Arvinas Ord (ARVN) | 0.2 | $5.5M | 285k | 19.17 | |
| Adverum Biotechnologies Com New (ADVM) | 0.2 | $5.0M | 1.1M | 4.67 | |
| Eledon Pharmaceuticals (ELDN) | 0.2 | $4.8M | 1.2M | 4.12 | |
| Elevation Oncology (ELEV) | 0.1 | $3.4M | 6.0M | 0.56 | |
| Immunocore Hldgs Ads (IMCR) | 0.1 | $3.2M | 109k | 29.50 |
